1356
A. P. Panarello et al. / Tetrahedron Letters 46 (2005) 1353–1356
Chem. Commun. 2003, 1860–1861; Kotha, S.; Lahiri, K.;
126.7, 126.6, 125.3, 123.9, 123.7, 122.4, 121.1, 119.6, 113.9,
113.7, 113.6, 39.2, 38.8. IR (mmax, cmꢀ1, NaBr): 3430, 2924,
1699, 1605, 1398, 1073, 908, 818 (C@C), 733, 698, 623–510
(ter-C@C). Toluene-4-sulfonic acid 2-(3H-inden-10-yl)-
ethyl ester (11).1H NMR (d, CDCl3): 7.83 (d, 1H), 7.73
(d, 2H), 7.45–7.35 (dd, 2H), 7.28 (d, 2H), 7.23 (d, 1H), 6.25
(s, 1H), 4.33 (t, 2H), 3.29 (s, 2H), 2.95 (t, 2H), 2.45 (s, 3H).
13C NMR (d, CDCl3): 144.7, 144.3, 144.1, 138.7, 130.5,
129.8, 127.8, 126.2, 124.9, 123.9, 118.6, 68.7, 37.9, 37.9,
Sreenivasachary, N. Synthesis 2001, 1932–1934; Shultz, D.
A.; Gwaltney, K. P.; Lee, H. J. Org. Chem. 1998, 63, 769–
774.
12. General procedure of indene alkylation. Under argon,
indene and dry THF (20 Mequiv) were charged to an oven
dried reaction flask and placed in an ice bath. BuLi (1.6 M,
1 Mequiv) was dropwise added yielding a deep red
solution. The reaction mixture was then allowed to slowly
warm up to room temperature over 1 h. A second flask
was purged with argon and charged with the appropriate
alkylating agent (1.05 Mequiv) and THF (40 Mequiv).
The indenyllithium solution was then dropwise added to
the alkylating agent at room temperature using a syringe
pump (15 mL/h). A syringe pump allowed for better
control of the addition rate, which proved critical for the
selective alkylation reactions. The reaction was then
allowed to stand over night at room temperature and
quenched the following morning using an saturated
aqueous NH4Cl solution. CH2Cl2 was added and a
liquid–liquid extraction was performed. The organic phase
was then collected and dried with MgSO4. The solvent was
removed under reduced pressure, and obtained oil was
purified by Flash Column Chromatography with elution
by hexane or its mixture with ethyl ether (EE).
27.5, 21.7. MS (m/z): 337 (M++Na+). IR (mmax, cmꢀ1
,
NaBr): 3065–20 (m), 2959–2856 (m), 1709, 1598, 1461,
1359 (S@O), 1176 (S–Ph), 1096, 980–960, 904, 771, 662. 3-
(20-Bromoethyl)-1H-indene (12). 1H NMR (d, CDCl3):
7.5–7.2 (m, 4H), 6.38 (s, 1H), 3.72 (t, 2H), 3.39 (s, 2H),
3.18 (t, 2H). 13C NMR (d, CDCl3): 144.3, 144.2, 137.5,
129.9, 124.9, 124, 122.9, 118, 34.7, 31.5, 30.6. 3-(20-
Chloroethyl)-1H-indene (13). 1H NMR (d, CDCl3): 7.45
(d, 1H), 7.4–7.3 (m, 2H), 7.2–7.25 (t, 1H), 6.35 (s, 1H),
3.73 (t, 2H), 3.39 (s, 2H), 3.05 (t, 2H). 13C NMR (d,
CDCl3): 144.6, 140.4, 130, 126.2, 124.9, 123.9, 118.6, 42.7,
37.9, 31.3. 6-Bromo-3-[20-(3H-inden-100-yl)-ethyl]-1H-ind-
1
ene (14). H NMR (d, CDCl3): 7.45 (d, 1H), 7.4 (d, 2H),
7.35 (s, 2H), 7.25 (d, 2H), 6.29 (s, 2H), 3.35 (s, 4H), 2.95 (s,
4H). 13C NMR (d, CDCl3) 147.7, 146.6, 145.3, 144.5,
143.9, 143.7, 143.6, 143.2, 129.7, 129.1, 128.4, 128.1, 127.3,
127.1, 126.1, 125.1, 124.7, 123.9, 122.2, 120.3, 120.1, 118.9,
118.8, 37.8, 37.7, 37.5, 26.2, 26.1. IR (mmax, cmꢀ1, NaBr):
3063, 2902, 1599, 1563, 1459, 1396, 1273, 1245, 1230, 1202,
1168, 1121, 1059, 1014, 967, 917, 863 (C@C), 809 (C@C),
773 (C@C), 719 (C@C). Elemental analysis (%): C20H17Br,
C: 71.2(calcd), 69.32(found), H: 5.08 (calcd), 5.07
(found). 1-[20-(3H-Inden-100-yl)ethyl]-5-(4000-vinylphenyl)-
3H-indene (15). Mp (°C): 104 (hexane). 1H NMR (d,
CDCl3): 7.75 (s, 1H), 7.6 (d, 2H), 7.59 (d, 1H), 7.5 (dd,
4H), 7.45 (t, 1H), 7.35 (t, 1H), 7.25 (t, 1H), 6.85–6.75 (q,
1H), 6.35 (d, 2H), 5.85–5.78 (d, 1H), 5.32–5.25 (d, 1H),
3.45–3.39 (d, 4H), 2.9 (s, 4H). 13C NMR (d, CDCl3):
197.9, 145.3, 144.8, 144.5, 144.1, 144, 137.3, 136.5, 136.2,
128.5, 128, 127.4, 127.2, 126.6, 126, 125.1, 124.6, 123.8,
13. Collins, S.; Bradly, A.; Taylor, N. J.; Ward, D. G. J.
Organomet. Chem. 1988, 342, 21–29.
14. Armus, J.; Kolis, S. P.; Hoveyda, A. H. J. Am. Chem. Soc.
2000, 122, 5977–5983, Used a similar procedure and
replaced the alkenyl-tosylate with 2-chloroethyl p-
toluenesulfonate.
15. Analytical data. 5-(40-Hydroxymethyl-phenyl)-indan-1-
one (3). Mp (°C): 156 (THF). 1H NMR (d, CDCl3): 7.9
(d, H), 7.7–7.55 (m, 4H), 7.45 (d, 2H), 4.75 (s, 2H), 3.2 (t,
2H), 2.78 (t, 2H), 1.75 (br s, 1H). 13C NMR (d, CDCl3):
155.9, 147.3, 141.1, 139.5, 136, 127.7, 127.5, 126.7, 125.1,
124.1, 64.9, 36.5, 25.9. MS (APPI, m/z): 261 (M++Na+).
IR (mmax, cmꢀ1, NaBr): 3380 (OH), 2925–2825, 1682
(C@O), 1608, 1440, 1405, 1300, 1199, 1111, 1058, 799, 636.
6-[40-(Hydroxymethyl)phenyl]-1H-indene (4). 1H NMR (d,
CDCl3): 7.73 (s, 1H), 7.65 (d, 2H), 7.55–7.45 (m, 4H), 6.95
(d, 1H), 6.6 (d, 1H), 4.75 (d, 2H), 3.49 (s, 2H), 1.65 (t, 1H).
13C NMR (d, CDCl3): 144.5, 144.2, 141.2, 139.4, 137.4,
134.7, 131.8, 127.5, 127.3, 125.5, 122.6, 121.1, 65.2, 39.2.
122.5, 119.1, 118.9, 113.6, 37.9, 37.8, 26.3 IR (mmax, cmꢀ1
,
NaBr): 3049, 2920, 1715, 1603 (C@C), 1460, 1396, 1265,
1167, 1060, 914, 821, 770, 736. 1-[20-(3H-Inden-100-
yl)ethyl]-5-[4000-(hydroxymethyl) phenyl]-3H-indene (16).
1H NMR (d, CDCl3): 7.79–7.72(m, 1H), 7.7–7.65 (m-t,
3H), 7.55–7.45 (m, 5H), 7.35 (d, 1H), 7.25 (d, 1H), 6.3 (br
s, 2H), 4.75 (s, 2H), 3.45–3.75 (dd, 4H), 3.0 (d, 4H), 2.2(br
s, 1H). 13C NMR (d, CDCl3): 146.2, 145.2, 144.5, 144.1,
144, 143.7, 141.3, 139.5, 139.1, 129.9, 128.7, 128.5, 128.1,
128, 127.5, 127.4, 127.3, 126, 125.2, 124.6, 124, 123.8,
123.8, 122.6, 119.1, 118.9, 117.6, 66.7, 37.9, 37.8, 26.3,
26.2. IR (mmax, cmꢀ1, NaBr): 3427 (OH), 2924, 2854, 1699,
1604, 1580, 1541, 1470, 1362, 1176, 1045 (OH), 1013 (OH),
919, 816 (C@C), 769 (C@C), 664, 554. 1-(20-Bromoethyl)-
MS (m/z): 108 (BzOH+), 116 (Ind+). IR (mmax, cmꢀ1
,
NaBr): 3335–3240 (OH), 2920–2860, 1613, 1465, 1405,
1120, 1050 (–OH), 1010, 806 (C@C), 682. 6-{40-[(Triiso-
1
propylsiloxy)methyl]phenyl}-1H-indene (5). H NMR (d,
CDCl3): 7.75 (s, 1H), 7.63 (d, 2H), 7.57 (d, 1H), 7.5–7.4
(d(s), 3H), 6.95 (d, 1H), 6.6 (d, 1H), 4.95 (s, 2H), 3.49 (s,
2H), 1.15 (d, 3H), 1.05 (br s, 18H). 13C NMR (d, CDCl3):
144.5, 144.2, 140.6, 140.5, 138, 134.7, 132, 127.2, 125.6,
122.8, 121.3, 65.1, 39.4, 18.3, 17.9, 12.3. MS (APPI, m/z):
237, 379 (M+). 6-{40-[(Methoxymethoxy)methyl]phenyl}-
1
1H-indene (25). H NMR (d, CDCl3): 7.55–7.25 (m, 4H),
1
1H-indene (6). H NMR (d, CDCl3): 7.7 (s, 1H), 7.6 (d,
6.93 (d, 1H), 6.6 (d, 1H), 3.78 (t, 1H), 3.45 (t, 2H), 2.52–2.4
(m, 1H), 2.25–2.1 (m, 1H). 13C NMR (d, CDCl3): 146.3,
141.3, 131.9, 129.9, 126.9, 126.2, 125.1, 121.3, 49.6, 37.9,
31.6. 1-(20-Chloroethyl)-1H-indene (26). 1H NMR (d,
CDCl3): d 7.45 (d, 1H), 7.4 (d, 1H), 7.35–7.2(m, 2H),
6.85 (d, 1H), 6.55 (d, 1H), 3.7 (t, 1H), 3.6 (t, 2H), 2.4–2.27
(m, 1H), 2.15–2.0 (m, 1H).
2H), 7.55–7.42 (m, 4H), 6.95 (dt, 1H), 6.6 (dt, 1H), 4.75 (s,
2H), 4.65 (s, 2H), 3.55 (s, 3H), 3.45 (s 2H). 13C NMR (d,
CDCl3): 144.4, 144.2, 141.3, 137.5, 136.4, 134.7, 131.7,
128.4, 127.2, 125.5, 122.6, 121.1, 95.7, 69, 55.4, 39.2. IR
(mmax, cmꢀ1, NaBr): 2960–30, 2865, 1761, 1644, 1598,
1467, 1368, 1291, 1181, 1089 (MOMO), 1046, 958, 813
(C@C), 767, 661. 6-(40-Vinylphenyl)-1H-indene (9). 1H
NMR (d, CDCl3): 7.73–7.65 (d, 1H), 7.6 (d, 2H), 7.6–7.55
(m, 1H), 7.5 (d, 2H), 7.48–7.45 (m, 2H), 6.95 (t, 1H), 6.83–
6.73 (q, 1H), 6.62(t, 1H), 5.85–5.75 (d, 1H), 5.3–5.28 (d,
1H), 4.0–3.95 (d, 2H). 13C NMR (d, CDCl3): 145.6, 144.4,
144.2, 142.9, 141.3, 141.2, 139.2, 137.3, 136.5, 136.4, 136.3,
136.2, 134.9, 134.7, 132.1, 131.8, 127.4, 127.3, 127, 126.9,
16. Compound 3 was purified by the addition of THF to the
reaction mixture followed by a liquid–liquid extraction
where the organic phase was collected, dried with MgSO4,
and concentrated.
17. The isolated product confirms to previously published
results: Kauffman, T.; Berghus, K.; Rensing, A. Chem.
Ber. 1985, 118, 3737–3747.